| ev3 Inc. - Medical Equipment - Deals and Alliances | | | | - Gives information on the company's major recent |
| Profile is an essential source for company data and | | | | financial deals including mergers & acquisitions, |
| information. The profile examines the company's key | | | | asset transactions, PE/VC deals, equity offerings, |
| business structure and operations, history and | | | | debt offerings and partnerships. |
| products, and provides summary analysis of its key | | | | - Data is supplemented with details on the company's |
| revenue lines and strategy as well as highlighting the | | | | history, key executives, business description, |
| company's major recent financial deals.ev3 Inc. (ev3) | | | | locations and subsidiaries as well as a list of products |
| is a global medical device company engaged in | | | | and services and the latest available company |
| developing catheter based or endovascular | | | | statement. |
| technologies for the minimally invasive treatment of | | | | Reasons to buy |
| vascular diseases and disorders. The company | | | | - A quick "one-stop-shop" to understand the |
| principally operates in the US, Canada, Europe and | | | | company. |
| other countries. It is headquartered in Minnesota, the | | | | - Support sales activities by understanding your |
| US. The company has been dedicated to improve the | | | | customers' businesses. |
| lives of patients with vascular disease through the | | | | - Qualify prospective partners and suppliers. |
| development of innovative endovascular therapies. | | | | - Understand and respond to your competitors' |
| ev3 is a best-in-class technology provider for | | | | business structure, strategy and prospects through. |
| specialists treating a wide range of peripheral vascular | | | | - Understanding the key deals which have shaped the |
| and neurovascular diseases. | | | | company. |
| And More inside the report… | | | | Company MentionedThe following companies are the |
| Recent Developments | | | | major competitors of ev3 Inc.: |
| Dec 15, 2009: Ev3 Promotes Pascal E.R. Girin To EVP, | | | | C. R. Bard, Inc. |
| COO And David Mowry To SVP, President | | | | IDev Technologies, Inc. |
| Oct 27, 2009: ev3 Reports Net Income Of $6.7 Million | | | | Pathway Medical Technologies, Inc. |
| In Q3 2009 | | | | Cardiovascular Systems, Inc. |
| Jul 28, 2009: ev3 Posts Net Income Of $24 Million In | | | | MEDRAD, Inc. |
| Q2 2009 | | | | The Spectranetics Corporation |
| Scope | | | | Terumo Corporation |
| - Provides key company information for business | | | | Micrus Endovascular Corporation |
| intelligence needs | | | | Medtronic, Inc. |